Rankings
▼
Calendar
MCK Q3 2023 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena
MCK
McKesson Corporation
$115B
Q3 2023 Earnings
Healthcare
Medical - Distribution
Income Statement
Revenue
$70.5B
+2.7% YoY
Gross Profit
$3.0B
4.2% margin
Operating Income
$1.1B
1.6% margin
Net Income
$1.1B
1.5% margin
EPS (Diluted)
$7.65
QoQ Revenue Growth
+0.5%
Cash Flow
Operating Cash Flow
$1.7B
Free Cash Flow
$1.5B
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$62.7B
Total Liabilities
$64.8B
Stockholders' Equity
-$2.5B
Cash & Equivalents
$2.8B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$70.5B
$68.6B
+2.7%
Gross Profit
$3.0B
$3.3B
-10.6%
Operating Income
$1.1B
$323M
+253.6%
Net Income
$1.1B
-$7M
+15514.3%
Revenue Segments
U.S. Pharmaceutical Segment
$61.9B
88%
International Segment
$4.4B
6%
Medical-Surgical Solutions Segment
$3.0B
4%
Prescription Technology Solutions
$1.1B
2%
← FY 2023
All Quarters
Q4 2023 →